查看犬血管肉瘤化疗管理 – 更新的源代码

== Reference ==

* 1. Göritz M, Müller K, Krastel D, Staudacher G, Schmidt P, et al. (2013) Canine splenic haemangiosarcoma: influence of metastases, chemotherapy and growth pattern on post-splenectomy survival and expression of angiogenic factors. J Comp Pathol 149(1): 30-39.
* 2. Sabattini S, Bettini G, (2009) '''An immunohistochemical analysis of canine haemangioma and haemangiosarcoma'''. J Comp Pathol 140(2- 3): 158-168.
* 3. Lamerato KAR, Helm KM, Jubala CM, Cutter GC, Modiano JF (2006) Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Exp Hematol 34(7): 870- 878.
* 4. Gorden BH, Kim JH, Sarver AL, Frantz AM, Breen M, et. al (2014) Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. Am J Pathol 184(4): 985-995.
* 5. Benjamin SA, Hahn FF, Chiffelle TL, Boecker BB, Hobbs CH, et al. (1975) Occurrence of hemangiosarcoma’s in beagles with internally deposited radionuclides. Cancer research 35(7): 1745-1755.
* 6. Gross TL, Ihrke PJ, Walder EJ, Affolter VK, (2005) Vascular tumors. Skin Diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis, (2nd edn). TL Gross, PJ Ihrke, EJ Walder, and VK Affolter (Eds.) Blackwell Publishing, Iowa pp: 944.
* 7. Ward H, Fox LE, Calderwood-Mays MB, Hammer AS, Couto CG (1994) Cutaneous hemangiosarcoma in 25 dogs: a retrospective study J Vet Intern Med 8(5): 345-348.
* 8. Sorenmo K, Duda L, Barber L, Cronin K, Sammarco C, et al. (2000) Canine hemangiosarcoma treated with standard chemotherapy and minocycline. J Vet Intern Med 14(4): 395-398.
* 9. Waters DJ, Hayden DW, Walter PA, (1989) Intracranial lesions in dogs with hemangiosarcoma. Journal of veterinary internal medicine 3(4): 222-230.
* 10. Schultheiss PC (2004) A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Invest 16(6): 522-526.
* 11. Tsuji N, Furukawa S, Ozaki K (2013) Cutaneous hemangiosarcoma in a dog. J Toxicol Pathol 26(2):193-195.
* 12. U’ren Hillers KR, Lana SE, Fuller CR LaRue SM (2007) Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs. J Am Anim Hosp Assoc 43(4): 187-192.
* 13. Ogilvie GK, Powers BE, Mallinckrodt C H, Withrow SJ, (1996) Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 10(6): 379-384.
* 14. Wiley JL, Rook KA, Clifford CA, Gregor TP, Sorenmo KU (2010) Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma. Vet Comp Oncol 8(3): 221-233.
* 15. Bulakowski EJ, Philibert JC, Siegel S, Clifford CA, Risbon R, et al. (2008) Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001–2006) J Am Vet Med Assoc 233(1): 122-128.
* 16. Finotello R, Stefanello D, Zini E, Marconato L, (2017) Comparison of doxorubicin–cyclophosphamide with doxorubicin–dacarbazine for the adjuvant treatment of canine hemangiosarcoma. Vet Comp Oncology 15(1): 25-35.
* 17. Hammer AS, Couto CG, Filppi J, Getzy D, Shank K, (1991) Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 5(3): 160-166.
* 18. U’ren LW, Biller BJ, Elmslie RE, Thamm DH, Dow SW (2007) Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma. J Vet Intern Med 21(1): 113-120.
* 19. Reckelhoff CR, Lejeune A, Thompson PM, Shiomitsu K (2019) In vitro effects of the chemotherapy agent water-soluble micellar paclitaxel (Paccal Vet) on canine hemangiosarcoma cell lines. Veterinary and comparative oncology 17(1): 32-41.
* 20. Carlson A, Alderete KS, Grant MKO, Seelig DM, Sharkey LC, et al. (2018) Anticancer effects of resveratrol in canine hemangiosarcoma cell lines. Veterinary and comparative oncology 16(2): 253-261.


* [[狗狗心包积液]]

<br>